Everyday Health on MSN

5 Myths About GLP-1s for Weight Loss

Uncover common misconceptions about GLP-1s for weight loss. Learn the importance of diet, exercise, managing side effects, ...
CHICAGO (WLS) -- Geraldine Glass said her diabetes medication has been on back order for weeks because so many people are using the drug to lose weight. Drugs to treat diabetes have become ...
Navigating the realm of medical treatments often leads us to a crossroads where traditional prescriptions and natural alternatives meet. Liraglutide, a name familiar in many healthcare conversations, ...
Talk about a leg up. Researchers say that taking a popular obesity medication and exercising regularly can lead to weight loss — and bone health is still maintained. Bone loss typically accompanies ...
Ozempic shortages expected throughout 2024 Victoza shortages expected until at least Q2 2024 Diabetes drug Ozempic used 'off label' to treat obesity Nov 21 (Reuters) - Novo Nordisk (NOVOb.CO), opens ...
Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. Doctors say it can be extremely ...
The FDA approved the first-ever generic form of a GLP-1 receptor agonist specifically indicated for weight loss, Teva Pharmaceuticals announced Thursday. The generic form of liraglutide (Saxenda) is ...
The new research tested the drug liraglutide, marketed as the diabetes treatment Victoza. Liraglutide and the active substance used in the weight-loss treatment Wegovy are both GLP-1 agonists, used to ...
New drugs that spur weight loss and treat diabetes have been taking the public—and the pharmaceutical industry—by storm. The latest entrant, Zepbound, recently joined Ozempic, Wegovy, Victoza and ...
Since winning over fans in Superbad, actor Jonah Hill has become a beloved presence in Hollywood. But beyond his career, he’s faced struggles with self-confidence and losing weight. Over the years, he ...
A new study for the HSE has found that making the weight loss drug Mounjaro available to public patients would not be value ...